key: cord-0702801-9alivtkt authors: Traini, Marco Claudio; Caponi, Carla; Ferrari, Riccardo; De Socio, Giuseppe Vittorio title: Modelling SARS-CoV-2 unreported cases in Italy: Analysis of serological survey and vaccination scenarios date: 2021-07-13 journal: Infect Dis Model DOI: 10.1016/j.idm.2021.06.002 sha: 4e1adf3f6af3822439c82a3dc2fb3f128dbadaf7 doc_id: 702801 cord_uid: 9alivtkt OBJECTIVES: Aim of the present paper is the study of the large unreported component, characterizing the SARS-CoV-2 epidemic event in Italy, taking advantage of the Istat survey. Particular attention is devoted to the sensitivity and specificity of the serological test and their effects. METHODS: The model satisfactory reproduces the data of the Italian survey showing a relevant predictive power and relegating in a secondary position models which do not include, in the simulation, the presence of asymptomatic groups. The corrections due to the serological test sensitivity (in particular those ones depending on the symptoms onset) are crucial for a realistic analysis of the unreported (and asymptomatic) components. RESULTS: The relevant presence of an unreported component during the second pandemic wave in Italy is confirmed and the ratio of reported to unreported cases is predicted to be roughly 1:4 in the last months of year 2020. A method to correct the serological data on the basis of the antibody sensitivity is suggested and systematically applied. The asymptomatic component is also studied in some detail and its amount quantified. A model analyses of the vaccination scenarios is performed confirming the relevance of a massive campaign (at least 80000 immunized per day) during the first six months of the year 2021, to obtain important immunization effects within August/September 2021. Characteristic feature of the present coronavirus pandemic is that many of the persons who contract the disease are asymptomatic (never symptomatic or mild symptomatic) and largely responsible for the infection transmission (Johansson et al. , 2021) [22] . In fact the spread of severe acute respiratory syn- 5 drome coronavirus 2 (SARS-CoV-2) throughout the world has been extremely rapid suggesting the hypotheses of a crucial rôle played by those infected persons who remain asymptomatic even if contagious (Buitrago-Garcia, 2020) [6] . A recent paper by Ora and Topol, (Oran, 2020) [31] , summarizes the available evidences on asymptomatic SARS-CoV-2 infection concluding that "asymptomatic 10 persons seem to account for approximately 40% to 45% of the SARS-CoV-2 infections, and that they can transmit the virus to others for an extended period of time, perhaps longer than 14 days". Oran and Topol (Oran, 2020) [31] conclude with the need "that testing programs include those without symptoms". Other works estimate the fraction of asymptomatic patients to be more than reporting results of a detailed survey in the small town of Vo' (near Padua, Italy) where on February 21 st a lockdown was imposed in the whole municipality as a first outbreak in Italy. After the lockdown they found a prevalence of 1.2% (95% CI:0.8-1.8%). Notably, 42.5% (95% CI:31.5-54.6%) of the confirmed SARS-CoV-2 infections detected across two surveys were asymptomatic (i.e. they did not manifest symptoms at the time of swab testing and did not de- 25 velop symptoms afterwards). After that a number of studies and projects have been developed to identify the rôle of asymptomatic in the pandemic infection in various countries (e.g. Buitrago-Garcia, 2020 [6]; Guerriero, 2020 [16] ; Peterson, 2020 [33] ; Pollán, 2020 [34] ; Snoeck, 2020 [39] ; Well, 2020 [48] ; Yanes-Lane, 2020 [50]). 30 In August 2020 preliminary results of a seroprevalence survey have been presented for a set of 64660 persons in Italy [18] . The Italian National Institute of Statistics (Istat) survey aimed to define (within the entire population) the portion of persons that developed an antibody response against SARS-CoV-2. The survey adopted a methodology allowing the evaluation of the 35 seroprevalence in the population also estimating the fraction of asymptomatic infections and the differences for age groups, sex, localization etc. The results involve a restricted number of tests, in particular those ones whose results have been reported before July 27 th . The post-stratified techniques adopted (Little, 1993) [25] allow to obtain statistical estimates coherent with epidemic data (both 40 at the international and local level). The main results of the Istat ) [18] . The amount of IgG positive tests corresponds to an infected population of (almost) 1.5 million of individuals in Italy, when the official reported cases are 244708 till July 27th, 2020. group also leads to the latter getting infected, with a similar probability. The seminal paper by Robinson and Stilianakis (Robinson, 2013) [36] formulates and investigates a preliminary model that, in addition to the exposed class, captures the asymptomatic phenomenon and it could be called SEAIR, since the corresponding model including exposed (E) group only is usually called SEIR. The two models differ in many aspects from a mathematical point of view; [42] , (Tang, 75 2020b) [43] . The uncertainties introduced by the serological test sensitivity and its time-dependence produce large effects in the identification of the antibody presence and are discussed in detail in Section 3.1 and Section 3.2. Section 4 is devoted to the study of vaccination scenarios and the rôle of unreported cases. Section 5 is devoted to some concluding remarks. The present Section is devoted to the validation of the model (and predictions) with the most recent data on the second epidemic wave in Italy (after September 25 th , 2020), in particular the predictions for the unreported compo-85 nents. The parametrization is based on values indicated in Table II The simple raison is that the model has been applied for the first time to the data of the second wave, in November 13 th . After that date, the additional official data have been added to the Figure Conversely, a (population-based) sero-epidemiological survey can quantify 130 the portion of population which developed antibodies agains SARS-CoV-2 providing information on the exposed individuals and on the remaining susceptible persons (assuming that antibodies are marker of total or partial immunity ii) the social contact rate regime is rather stable during the collection of data. In this way the fraction of infected population is (on average) connected with the transmission probability of the infection which is assumed to be constant. In the present model β = (1.5851 ± 0.0336) · 10 −8 day −1 , (cfr. The assumption i) sounds reasonable and the assumption ii) can be explicitly checked in our model by defining the following (time dependent) ratio (2) The numerator, in Eq. (2), counts, for each day, the total number of infected (re- a crucial information to evaluate in a quantitative way the amount of asymptomatic cases. The relation between unreported and asymptomatic distributions will be further discussed in Section 3.3 after a deeper analysis of the survey results. For the moment let us come back to the model ratio (2), as it is shown in One gets: . (4) The cyan curves in Fig. 5 summarize the model predictions for the ratio (4). The black curve representing the mean value and the dotted lines the normal distributed variations. In the next Section the results of the Istat survey will be compared with the predictions of the model, but we want to emphasize that the comparison will privilegiate the form of ratios like (1) The results of the Istat survey can be transformed in an analogous ratio in a 210 simple way: the absolute value corresponds to an average value of the prevalence (2.3 + 2.6)/2 ≈ 2.5 (cfr. Table 1 ). Therefore the upper and lower limit of the infected population divided by the reported cases is summarized by the ratio 2 which now includes the uncertainties estimated in the Istat survey and updates the crude approximation (1). The data points in Fig. 5 give a graphical rep-215 resentation of the ratio (5) assumed, in a first step, to be time-independent on the basis of the assumption i) and ii) already discussed. From this first analysis one can conclude that: 1. the global comparison in published before the Istat survey (Traini, 2020) [44] ; data confirm that the epidemiological models can offer predictions rather stable and realistic also for the Asymptomatic compartment. In particular the good agreement of The method introduced in the previous Section in order to learn on asymptomatic prevalence from serological tests and surveys, needs further considerations before extracting detailed information. Critical effects to be considered are the uncertainties due to sensitivity and specificity of the serological tests 255 and the rôle played by time dependence of the antibody response. A first correction to the seroprevalence analysis presented in the previous Section is due to the sensitivity and specificity of the serological tests adopted which replaces the value (5) to take into account the (asymmetric) corrections due to false responses. Fig. 5 is, consequently, replaced by Fig. 6 where the model results are compared with the more elaborated analysis. The asymmet- The sensitivity of the test decreases from not less than 90% to 81.3% (the false tests from 10% to 18.7%), while the specificity remains not less than 95%. Taking into account the new estimated sensitivity (7), and repeating the 13 J o u r n a l P r e -p r o o f calculations leading to Eq. (6), the ratio (6) is replaced by where (18.7% × 5.94 ≈ 1.11). The Fig. 6 is replaced by Fig. 7 . The asymmetric 310 increase of the error-bars is again clearly shown, and the conclusions drawn in Section 2.3 become more weak. 1. The comparison between the model estimates and the data corrected for the time dependence of the sensitivity of the tests as in Fig. 7 is less accurate and the data cannot be considered a stringent test for models. The estimate of the asymptomatic prevalence remains valid, but with a larger interval of confidence. Model and corrected data are still consistent for the whole time period. of the unknown asymptomatic distribution within a larger interval of val-320 ues. A more careful analysis of the Istat data, in particular the reference to the mentioned questionnaire (Istat Questionnaire 2020, [19] ) could help in making again the comparison more stringent. We are now in a position to disentangle, in more detail, the distribution of 325 asymptomatic cases from the unreported ones. A first example has been given in Fig. 3 where the model simulation has been used to separate the two components: unreported-asymptomatic and unreported-symptomatic distributions. A second step can be performed by means of the results of the Istat survey. An attempt is illustrated in Fig. 8 Table 1 and numerically elaborated in the footnote of pag. 9, 340 one hasĀ The same analysis can be written in our privilegiate form by means of the ratio 5Ā survey = 58.5% × 244708 × (5.94 ± 0.36) = 58.5% × reported cases × ratio| survey . Even if it can appear rather cryptic, Eq. (12) In order to compare those values with the model predictions one has to use the analogous quantities of Eq. (12) for the model, namely: i) the "reported cases", which are approximately the same since the model reproduces the empirical data; ii) the ratio between unreported+reported cases and reported cases as given by the " cumulative ratio| model " of Eq. (4). Numerically such ratio remains approximately constant for the period of interest (cfr. cyan curves in Fig. 5 ): cumulative ratio| model ≈ 5.6 ± 0.8; iii) third crucial ingredient is the ratio between the asymptomatic and symptomatic unreported cases as illustrated in Fig. 3 ,Ā model /Ī model ≈ 8, as already anticipated in Section 2.2 . The final expression reads The survey result (13) and the model prediction (15) a 20% accuracy result. The present Section is devoted to a hot aspect of the recent discussion on A preliminary aspect is the assessment of a possible vaccination scenario. We do not discuss specific strategies, but we want to establish general scenarios to illustrate main advantages and disadvantages within simple assumptions. Basically we will assume that the year 2021 will be devoted to vaccination in Italy and that the order of magnitude of the vaccinated (immunized) persons 385 per day is between 40000 and 80000 (to be selected with specific social and homogeneity criteria) (e.g. Makoul, 2020) [26] . In the following two basic scenarios will be introduced, as illustrated in Fig. 9 . i Fig. 9 ). The effort to start with such large portion of population suddenly is high and a second scenario is also investigated; ii) The second scenario assumes that the amount of persons immunized dur-395 ing the first period is rather low and the process will accelerate during the year (dot-dashed line in Fig. 9 , scenario (2-A). The Section is devoted to a general perspective of the year 2021 offering a macroscopic view of the pandemic event in Italy and the advantages of the (1-C). Also the scenario (2-A) has been implemented in the model and one can see the effects of a slow rate at the beginning of the year in the same Fig. 10 (dot-dashed line). The results of the vaccination are almost invisible till the end 2020) [30] . Last (not least) we ignore possible vaccine resistant variants that could appear during the year. 6 The oscillating behavior is simulated by an oscillating contact rate c(t) = c 0 + 10 c 0 · cos 2 (Ωt), with 0 ≤ t ≤ 365 and Ω = 4π/365, cfr. (1-B) . The conclusions of the previous discussion on vaccination strategies as they emerge from Fig. 10 can appear rather unintuitive. It appears rather hard to accept the rapid reduction of the reported cases in one single year (initial value 575000) also in a scenario with no-vaccination. To partially restore intuition, one has to realize that, following the results of The traditional compartmental classes of Susceptible, Exposed, Infected and Notably, 42.5% (95% CI:31.5-54.6%) of the confirmed SARS-CoV-2 infections were asymptomatic (that is did not have symptoms at the time of positive swab testing and did not develop symptoms afterwards, (Lavezzo, 2020) ). The Italian National Institute of Statistics (Istat) The Fig. 10 shows data referring to February 15 th , the updated situation is shown in Fig. 12 . The paper is the product of the joint work of the authors. We declare a non competing interest. Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence in Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis Understanding variants of SARS-CoV-2 Covid-19: Identifying and isolating asymptomatic people helped eliminate virus in italian village 2020. textitAntibody tests for identification of current and past infection with SARS-CoV-2 Estimation of seroprevalence of 540 novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: a cross-sectional study SARS-CoV-2 variants and ending the COVID-19 pandemic Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19 Seroprevalence of antibodies against SARS-CoV-2 among health care large Spanish reference hospital Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy Nature Medicine 26 Prevalence of asymptomatic SARS-CoV-2-positive individuals in the general population of northern Italy and evaluation of a diagnostic serological ELISA test: a crosssectional study protocol Data Analysis Recipes: Using Markov Chain Monte Carlo. The Astrophys Italian National Institute of Statistics Primi risultati dell'indagine di seroprevalenza sul SARS-CoV-2 Questionario-indagine-sieroprevalenza 2020 a. Modeling the Prevalence of Asymptomatic COVID-19 Infections in the Chinese Mainland. The innovation. 1. 1000026 False negative RT-PCR and false positive antibody tests-Concern and solutions in the diagnosis of COVID-19 SARS-CoV-2 Transmission From People Without COVID-19 Symptoms Containment, Contact Tracing and Asymptomatic Transmission of Novel Coronavirus Disease (COVID-19): A Modelling Study Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'. Nature. 584. 425 Post-Stratification: A Modeler's Perspective Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses. Vaccines. 8. 668 Estimating the 605 asymptomatic proportion of coronavirus disease 2019 (covid-19) cases on board the diamond princess cruise ship The impact of vac-610 cination on COVID-19 outbreaks in the United States Prevalence of Asymptomatic SARS-CoV-2 Infection The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19 outbreak Three Quarters of People with SARS-CoV-2 620 Infection are Asymptomatic: Analysis of English Household Survey Data Clin Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study COVID-19 and Italy: what next A model for the emergence of drug resistance in the presence of asymptomatic infections. Mathematical Bio-630 sciences Estimating the burden of SARS-CoV-2 in France Seroprevalence of COVID-19 virus 635 infection in Guilan province, Iran. Emerg Infect Dis Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study Seroprevalence of SARS-CoV-2-specific antibodies among adults in Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, Switzerland. The Lancet. 396. 313 Estimation of the Transmission 650 Risk of the 2019-nCoV and Its Implication for Public Health Interventions A study of SARS-CoV-2 epidemiology in Italy: from early days to secondary effects after social distancing Modeling the 660 asymptomatic prevalence of SARS-CoV-2 epidemic in Italy and the Istat survey SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak Estimates of the rate of infection and asymptomatic COVID-19 disease in a population 670 sample from SE England Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis Modeling return of the epidemic: Impact of population structure, asymptomatic infection, case importation and personal contacts